CHURCHILL RESOURCES INC (CRI.CA) Fundamental Analysis & Valuation

TSX-V:CRI • CA1715521029

Current stock price

0.13 CAD
-0.01 (-10.34%)
Last:

This CRI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CRI.CA Profitability Analysis

1.1 Basic Checks

  • CRI had negative earnings in the past year.
  • CRI had a negative operating cash flow in the past year.
  • In the past 5 years CRI always reported negative net income.
  • CRI had a negative operating cash flow in each of the past 5 years.
CRI.CA Yearly Net Income VS EBIT VS OCF VS FCFCRI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1M -2M -3M -4M -5M

1.2 Ratios

Industry RankSector Rank
ROA -60.16%
ROE -73.08%
ROIC N/A
ROA(3y)-112.05%
ROA(5y)-96.46%
ROE(3y)-185.18%
ROE(5y)-148.4%
ROIC(3y)N/A
ROIC(5y)N/A
CRI.CA Yearly ROA, ROE, ROICCRI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CRI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRI.CA Yearly Profit, Operating, Gross MarginsCRI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CRI.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CRI has been increased compared to 1 year ago.
  • Compared to 5 years ago, CRI has more shares outstanding
  • Compared to 1 year ago, CRI has a worse debt to assets ratio.
CRI.CA Yearly Shares OutstandingCRI.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRI.CA Yearly Total Debt VS Total AssetsCRI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

2.2 Solvency

  • An Altman-Z score of 13.72 indicates that CRI is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for CRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.72
ROIC/WACCN/A
WACCN/A
CRI.CA Yearly LT Debt VS Equity VS FCFCRI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M

2.3 Liquidity

  • A Current Ratio of 3.52 indicates that CRI has no problem at all paying its short term obligations.
  • A Quick Ratio of 3.52 indicates that CRI has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 3.52
CRI.CA Yearly Current Assets VS Current LiabilitesCRI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CRI.CA Growth Analysis

3.1 Past

  • CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.29%, which is quite impressive.
EPS 1Y (TTM)50.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CRI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CRI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRI.CA Price Earnings VS Forward Price EarningsCRI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRI.CA Per share dataCRI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CRI.CA Dividend Analysis

5.1 Amount

  • CRI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CRI.CA Fundamentals: All Metrics, Ratios and Statistics

CHURCHILL RESOURCES INC

TSX-V:CRI (4/27/2026, 7:00:00 PM)

0.13

-0.01 (-10.34%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.85%
Inst Owner ChangeN/A
Ins Owners19.48%
Ins Owner ChangeN/A
Market Cap41.17M
Revenue(TTM)N/A
Net Income(TTM)-4.28M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.03
P/tB 7.03
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -60.16%
ROE -73.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-112.05%
ROA(5y)-96.46%
ROE(3y)-185.18%
ROE(5y)-148.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.52
Quick Ratio 3.52
Altman-Z 13.72
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.01%
OCF growth 3YN/A
OCF growth 5YN/A

CHURCHILL RESOURCES INC / CRI.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHURCHILL RESOURCES INC (CRI.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRI.CA.


What is the valuation status for CRI stock?

ChartMill assigns a valuation rating of 0 / 10 to CHURCHILL RESOURCES INC (CRI.CA). This can be considered as Overvalued.


How profitable is CHURCHILL RESOURCES INC (CRI.CA) stock?

CHURCHILL RESOURCES INC (CRI.CA) has a profitability rating of 0 / 10.